A high-fat diet decreases GABA concentration in the frontal cortex and hippocampus of rats by unknown
Sandoval‑Salazar et al. Biol Res  (2016) 49:15 
DOI 10.1186/s40659‑016‑0075‑6
RESEARCH ARTICLE
A high‑fat diet decreases GABA 
concentration in the frontal cortex 
and hippocampus of rats
Cuauhtemoc Sandoval‑Salazar1, Joel Ramírez‑Emiliano2, Aurora Trejo‑Bahena2, Cecilia I. Oviedo‑Solís3 
and Martha Silvia Solís‑Ortiz2*
Abstract 
Background: It has been proposed that the γ‑aminobutyric acid (GABA) plays a key role in the regulation of food 
intake and body weight by controlling the excitability, plasticity and the synchronization of neuronal activity in the 
frontal cortex (FC). It has been also proposed that the high‑fat diet (HFD) could disturb the metabolism of glutamate 
and consequently the GABA levels, but the mechanism is not yet clearly understood. Therefore, the aim of this study 
was to investigate the effect of a HFD on the GABA levels in the FC and hippocampus of rats.
Results: The HFD significantly increased weight gain and blood glucose levels, whereas decreased the GABA levels in 
the FC and hippocampus compared with standard diet‑fed rats.
Conclusions: HFD decreases GABA levels in the FC and hippocampus of rat, which likely disrupts the GABAergic 
inhibitory processes, underlying feeding behavior.
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Background
Obesity is a serious and growing public health problem 
that reduces life expectancy and increases morbidity 
due to the development of complications, such as car-
diovascular diseases, glucose intolerance, hyperinsuline-
mia, type 2 diabetes, dyslipidemia, and hypertension [1]. 
Psychological factors, genetic predisposition and eating 
habits can induce obesity [1]. With respect to food hab-
its, an increased intake of diets rich in saturated fat can 
contribute to cognitive decline [2]. Thus, the high-fat 
diet (HFD)-induced obesity models have contributed sig-
nificantly to the study of the pathophysiology of insulin 
resistance, hyperglycemia, obesity and metabolic syn-
drome [3], might also be helpful to understand how HFD 
contributes to cognitive damage [2].
GABA (γ-aminobutyric acid) has been proposed to 
play a key role in the cognitive choice of selecting the 
type, quantity and quality of food by regulating the trans-
mission of signals between neurons in brain circuits [4]. 
GABA is the major inhibitory neurotransmitter in the 
mammalian brain and has been implicated in controlling 
excitability, the processing of information, plasticity, and 
the synchronization of neuronal activity [5]. Addition-
ally, the involvement of GABA in eating behavior has 
been supported in experiments using rodent models and 
GABA receptor agonists and antagonists [6]. Changes 
in brain glucose concentration can modify the release of 
neurotransmitters. For instance, hypoglycemic periods 
inhibit GABA release in the substantia nigra and ventral 
tegmental area (VTA), which are areas that project to the 
frontal cortex (FC), and increases dopamine concentra-
tion and disinhibits the FC [7].
The prefrontal cortex (PFC) plays a role in cognitive 
functions such as food selection [8], and PFC neurons 
are activated when individuals show a preference for 
an appetizing food instead of a non-appetizing one [8]. 
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Thus, in humans, it has been proposed that the disinhibi-
tion and asymmetry of the FC could induce eating disor-
ders by increasing anxiety and appetite, resulting in the 
development of obesity [9]. Additionally, it has been pro-
posed that the PFC plays a crucial role in the top-down 
control of behavior, especially under conflict situations 
when inappropriate responses need to be inhibited [10], 
likely by modulating GABA levels.
The PFC has connections with the medial temporal 
limbic system and outputs that include direct and indi-
rect connections with the amygdala, hypothalamus and 
hippocampus [11].
The hippocampus is involved in the regulation of the 
learning and memory functions [11] and recently has 
received increasing attention for its potential involve-
ment in the regulation of energy homeostasis and feed-
ing behavior through leptin signaling, which contributes 
to the non-homeostatic control of food intake by sup-
pressing the ability of contextual cues to elicit a memory 
for food [12]. A HFD alters glutamate metabolism and 
neurotransmission in the rat hippocampus, along with 
a significant change in glutamate uptake and a reduced 
synaptic efficacy [13]. Therefore, a HFD could disturb the 
metabolism of glutamate and consequently, GABA levels 
[14]. The hippocampal damage could alter body weight 
regulation [15], affecting processes that contribute to the 
control of appetite behavior [12].
Obesity reduces aptitude in learning tasks, includ-
ing decision making, memory and other cognition pro-
cesses in humans and animal models [8]. Most obese 
patients are impulsive and do not resist the consumption 
of foods that generate and/or maintain their obesity [16]. 
The effect of a HFD on GABA levels in the FC and hip-
pocampus is not well understood, but it is likely that the 
disturbance of GABA levels induces the development of 
overweight and obesity. Therefore, the aim of this study 
was to investigate the effect of a HFD on GABA levels in 
the frontal cortex and hippocampus of rats.
The present results indicate that a HFD decreases the 
GABA concentration in the FC and hippocampus. These 
findings also suggest that a HFD might disrupt processes 
of inhibition and subsequently alter food intake.
Results
Effect of a high‑fat diet on body weight gain
To examine the effect of HFD on the gain of body weight, 
the rats were weighted at the beginning of the HFD 
treatment and no significant differences were observed 
between the SD and HDF-fed rats (p = 0.6), Fig. 1. At the 
end of the treatment, the HFD group had a significant 
increase in body weight compared with the SD group 
(p = 0.0004). The HFD-fed rats gained significantly more 
weight than SD-fed rats (p = 0.014).
Effect of a high‑fat diet on biochemical parameters
Table  1 shows the serum glucose, cholesterol and tri-
glycerides levels. The glucose levels of the HFD-fed rats 
were significantly higher compared with the SD-fed rats 
(p = 0.001). The SD and HFD groups had similar choles-
terol levels (p = 0.168). The consumption of a HFD did 
not increase triglyceride levels after eight weeks of expo-
sure compared with the SD consumption (p = 0.87).
A high‑fat diet decreases GABA levels in the frontal cortex 
and hippocampus
Figure 2 shows the GABA levels in the FC and hippocam-
pus. The HFD-fed rats showed a significant decrease in 
their GABA levels in the FC compared with the SD-fed 
group (p = 0.00003), similar to the GABA levels in the hip-
pocampus in comparison with the SD-fed rats (p < 0.03).
Discussion
Hypercaloric diets can modify the GABA levels in the 
brain. As predicted, we found that a HFD administered to 
Fig. 1 Effect of high‑fat diet on body weight gain. SD, standard 
diet (n = 10); HFD, high‑fat diet (n = 10). Data are given as the 
mean ± standard error of the mean (SEM)
Table 1 Biochemical parameters of rats





T value P value
Glucose (mg/dl) 89 ± 9.3 155 ± 7.5 −5.53 0.001
Cholesterol (mg/dl) 83 ± 1.41 110 ± 17.8 −1.56 0.168
Triglycerides (mg/dl) 75 ± 3.9 89 ± 5.9 −2.04 0.87
Page 3 of 6Sandoval‑Salazar et al. Biol Res  (2016) 49:15 
rats for eight weeks increased the body weight and blood 
glucose and decreased the GABA concentration in the 
FC and hippocampus.
The body weight gain observed in the present study is 
consistent with studies in animal models, suggesting that 
exposure to high concentrations of carbohydrates or HFD 
contribute to the development of overweight or obesity 
[3]. Fat accumulation is stimulated when nutrients are 
led to the adipose tissue or to other tissues in which oxi-
dation is the immediate outcome [17]. Studies indicate 
that an imbalance in the activities of the glucose trans-
porter GLUT4 and lipoprotein lipase between muscle and 
adipose tissue may be important in the development of 
obesity [18]. Therefore, it is a logical conclusion that altera-
tions limiting lipolysis and fatty acid oxidation and stimu-
lating lipogenesis cause or are associated with obesity [19].
In rats, a diet with a high content of carbohydrates 
and fat increases the blood glucose levels [19]. This diet 
type eventually results in moderate hyperglycemia and 
impaired glucose tolerance in most rat and mouse strains 
[20]. C57BL/6  J mice fed with a HFD had higher glu-
cose levels [21], which is consistent with our data. Stud-
ies using hyperglycemia models have found that rats 
exposed to a hypercaloric diet for weeks develop changes 
in the blood glucose levels [22, 23]. We fed rats a HFD for 
eight weeks and also found increased glucose levels, but 
the cholesterol and triglycerides levels did not change. 
This may be due to the animals still having the ability 
to increase energy reserves without changing the blood 
levels of cholesterol and triglycerides. A large increase or 
decrease in the blood glucose level causes that the brain 
to respond and initiate compensatory responses to main-
tain glucose homeostasis [24]. Therefore, an increase in 
circulating glucose levels suggests that there is a distur-
bance in brain metabolism, which could increase the risk 
of developing overweight and obesity.
There is a relationship between HFD intake and neu-
rotransmitter concentration in the rat brain [13]. For 
instance, saturated fats and simple carbohydrates produce 
feelings of gratification by activating brain circuits through 
changing neurotransmitters levels [25]. Moreover, glucose 
modulates GABA and dopamine release in the substantia 
nigra (SN) and VTA [7]. Additionally, GABAergic neurons 
in the VTA have projections to many brain regions, includ-
ing the PFC, a structure involved in brain reward [7]. We 
found that the GABA concentration was lower in the FC of 
HFD-fed rats. It is likely that a HFD disturbs the inhibitory 
control of appetite and induces the development of obe-
sity by modulating cerebral neurotransmitter metabolism. 
Thus, GABA levels in PFC are thought to play a key role 
in the modulation of food intake and body weight gain, 
although the mechanism is not yet clearly understood.
The role of GABA in the PFC for the regulation of 
food intake is not well understood. In glia, GABA is 
degraded by the enzyme GABA-transaminase through 
the transamination reaction of α-ketoglutarate, produc-
ing l-glutamate, which leads to the formation of suc-
cinic semialdehyde [a negative allosteric modulator of the 
enzyme Glutamic Acid Decarboxylase-(GAD)] [26]. A 
study in rats suggests that obesity may be associated with 
decreased GABA production due to a disturbance in the 
GABA-glutamate-glutamine cycle in the hippocampus 
[14]. We found decreased GABA concentration in the PFC 
of rats fed a HFD, which could be detrimental to oxidative 
glucose metabolism and the synthesis of neurotransmitter 
(i.e., glutamate and GABA). This could cause homeostatic 
dysregulation between neurons and astrocytes. Thus, it is 
likely that this homeostatic dysregulation can affect the 
regulation of the eating behavior by promoting an imbal-
ance in the PFC and their connections with the reward 
system. The PFC receives highly processed gustatory and 
olfactory information along with limbic input from the 
amygdala and hippocampus and sends projections to the 
nucleus accumbens Shell, which is involved in profound 
hyperphagia by decreasing levels of GABA or the opiate 
receptor [27]. Pathological changes in vmPFC function 
impair the control of food intake and may facilitate eating 
disorders, obesity, and other disorders of appetitive moti-
vation [28]. Food intake was no measured and even not 
the role of GABA is not clear in this condition. We believe 
that a decrease in GABA levels might result in less inhibi-
tion of food intake. For example, Le et al. 2006 compared 
lean men with obese men and found a less postprandial 
activation in the left dorsolateral prefrontal cortex [29]. 
Fig. 2 Effect of high‑fat diet on GABA levels in frontal cortex and 
hippocampus. SD, standard diet (n = 10); HFD, high‑fat diet (n = 10). 
Data are given as the mean ± standard error of the mean (SEM)
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This area has seen implicated in the inhibition of inap-
propriate behavior and differential responses of neuronal 
activity to food intake. This area probably may contribute 
to a propensity for obesity or to the difficulty in losing 
weight experienced by obese men. Thus, it is important 
to evaluate the eating behavior and other cognitive pro-
cesses, which involve GABA, glutamate or dopamine.
The hippocampus is a brain structure that contains 
receptors for several hormonal signals, such as insulin and 
leptin, which may control energy balance [12]. A study 
in mice showed that a HFD alters glutamate metabolism 
and neurotransmission in the hippocampus, along with 
a significant change in glutamate uptake and a reduced 
synaptic efficacy [13]. Therefore, an HFD may disrupt the 
metabolism of glutamate and consequently that of GABA 
[14] and increase the number of reactive astrocytes and 
neurodegeneration [30]. Interestingly, we observed that 
the GABA concentration decreased in the hippocampus 
of HFD-fed rats compared with SD-fed rats, which sug-
gests an alteration in the process of feeding motivation. 
Therefore, these results allow for a better understanding of 
the relationship between HFD and GABA concentration.
In our opinion, the decrease of GABA levels could 
increase neuronal hyperexcitability. Thus, a reduction 
of GABA in the hippocampus and frontal cortex could 
decrease the processes of inhibitory control of food intake. 
Nevertheless, we did not measured the food intake, but a 
study found that obese individuals have a hypo-function-
ing reward circuitry, which suggest a less inhibitory func-
tion and therefore, the food appear to be more attractive 
to obese subjects during hunger state [31]. It is necessary 
other experiments which involve eating behavior like food 
choices and to determine the participation of other neu-
rotransmitters such as glutamate and dopamine.
Conclusions
The present results showed that a HFD reduced GABA 
levels in the FC and hippocampus. These findings suggest 
that the lower neurotransmitter levels in the FC and hip-
pocampus could impair the inhibitory processes under-
lying feeding behavior. The results also promote new 
strategies with pharmacological agonists and antagonists 
of GABA to understand how GABA level disturbances 
are involved in the brain mechanisms relating to obesity 
and probably imbalanced overeating.
Methods
Experimental animals
Twenty adult male Wistar rats that were of 2–3 months 
old (200–250  g of weight) were maintained in polypro-
pylene animal cages in a temperature-controlled envi-
ronment (22 ± 2 °C) and under a light–dark cycle set at 
12:12 h in the University of Guanajuato Animal Facility. 
All of the animal procedures in this study were con-
ducted in accordance with the National Research Council 
Guide for the Care and Use of Laboratory Animals and 
the Official Mexican Regulation for Experimentation in 
Animals (NOM-062-ZOO-1999).
Treatment with a high‑fat diet
The rats were randomized into two groups. The first 
group consisted of 10 rats fed a standard diet (Purina 
Rodent Chow; Purina Mexico), while the other group 
consisted of 10 rats fed a high-fat diet (Purina Chow, 
13 % lard; Purina Mexico). The Table 2 shows the com-
position of the diets. The two groups had access to water 
and chow ad libitum for eight weeks.
Collection of blood and tissue samples
At the end of the 8 week treatment, the rats were sacrificed 
by cervical dislocation. Immediately, 3 ml of blood was col-
lected directly from the heart and placed into tubes without 
anticoagulant to separate the serum. The tubes were centri-
fuged at 3000 rpm, and 500 μl aliquots of serum were stored 
at −20  °C. Subsequently, the FC and hippocampus were 
removed, dissected on ice-cold glass and stored in micro-
tubes at −80 °C until analysis. The FC and hippocampus tis-
sues were homogenized in Eppendorf tubes with 500 μl of 
0.1 M hydrochloric acid. The homogenates were centrifuged 
(10,000 × g, 4 °C, for 30 min). The supernatants were stored 
at −20 °C until analysis of the GABA concentration.
Determination of glucose, cholesterol and triglycerides 
levels
In serum, the glucose, total cholesterol and triglycer-
ides levels were measured using a spectrophotometric 
method and a SPINREACT Kit (Glucose-TR, GOD-POD; 
Cholesterol, CHOD-POD and Triglycerides GPO-POD 
and Enzymatic techniques. LAB CENTER MEXICO). 
The data are expressed as mg/dl.
Chemicals for GABA concentration determination
For determining the GABA concentration, the following 
reagents were used: (1) GABA; (2) Dns (1-dimethylamino 
naphthalene sulfonyl chloride), both purchased from 
Sigma, St. Louis, MO; (3) acetonitrile and hydrochloric acid 
Table 2 Comparison between  the composition of  the 
standard diet and the high fat diet
Standard diet (%) High fat diet (%)
Carbohydrates 58.5 48
Protein 23 29
Lipids (lard) 4.5 13
Others constituents 14 10
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were (from Karal SA de CV); (4) NaHCO3 and potassium 
hydroxide (from KEM Baker Analyzed, Inc. NJ USA); (5) 
high-performance liquid chromatography (HPLC) grade 
water (from the Department of Medical Science, León, 
Mexico); (6) an chromatographic column, Hydrosphere 
C18, 120A, 5 µM 150 × 4.6 mm (used for GABA separa-
tion and purchased from YMC Co., Ltd. Kyoto, Japan).
GABA level determination
The GABA level was quantified using HPLC–UV detec-
tion and acetonitrile–water (35:65, v/v) as the mobile phase. 
The derivatization of GABA was performed with Dns, using 
modified Kang´s method [32]. Stock solutions of GABA 
(1  mg/ml) were prepared in HPLC water. These solutions 
were diluted daily to working concentrations with water 
and were stored at 4 °C in the dark. The Dns solution was 
prepared just before derivatization by dissolving 200 mg of 
Dns in 10 ml of acetonitrile. All of the frozen samples were 
thawed just before the experiment. A total of 50 µl of the 
sample, 50 µl of 2 M NaHCO3–KOH solution (pH 9.8) and 
20 mg/ml of Dns in acetonitrile (50 µl) were mixed and incu-
bated at 80 °C for 30 min in a water bath under dark condi-
tions. Next, an aliquot (20 µl) of acetic acid was added to the 
tube to stop the reaction. The mixture was centrifuged at 
10,000 x g for 5 min. The supernatant (150 µl) was injected 
into the HPLC system, and the derivatives were measured at 
286 nm. The HPLC system included a GBC LC-1150 pump, 
a GBC 1650 Advanced Autosampler and a GBC LC1210 K 
UV–Vis Detector. The HPLC flow rate was 1.5 ml/min. All 
of the measurements were performed at room temperature.
Determination of protein content
The tissue protein content was determined according to 
the bicinchoninic acid method using bovine serum albu-
min as the standard.
Statistical analysis
The statistical analyses were performed with Statistics for 
Windows 8 (StatSoft, Inc.). Student’s t test was used to 
compare the body weight, biochemical parameters and 
GABA concentrations between the groups with the sig-
nificance level set at p < 0.05. The results were expressed 
as the mean ± standard error of the mean (S.E.M.).
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